LEASE AGREEMENTLease Agreement • February 9th, 2021 • Iovance Biotherapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 9th, 2021 Company IndustryTHIS LEASE AGREEMENT (this “Lease”) is made this 8th day of February, 2021, between ARE-SAN FRANCISCO NO. 63, LLC, a Delaware limited liability company (“Landlord”), and IOVANCE BIOTHERAPEUTICS, INC., a Delaware corporation (“Tenant”).
SECOND AMENDMENTOffice Lease • February 9th, 2021 • Iovance Biotherapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 9th, 2021 Company IndustryTHIS SECOND AMENDMENT (this “Amendment”) is made and entered into as of February 8, 2021, by and between HUDSON SKYWAY LANDING, LLC, a Delaware limited liability company (“Landlord”), and IOVANCE BIOTHERAPEUTICS, INC., a Delaware corporation (“Tenant”).
FIRST AMENDMENTOffice Lease • February 9th, 2021 • Iovance Biotherapeutics, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 9th, 2021 Company IndustryTHIS FIRST AMENDMENT (this “Amendment”) is made and entered into as of February 8, 2021, by and between HUDSON SKYWAY LANDING, LLC, a Delaware limited liability company (“Landlord”), and IOVANCE BIOTHERAPEUTICS, INC., a Delaware corporation (“Tenant”).